Publication View

Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation See Editorial on Page 1084

Abstract
Previous studies reported that hepatitis B virus (HBV) deoxyribonucleic acid (DNA) can be detected in livers of patients who received transplants for hepatitis B despite the absence of serological markers of HBV recurrence. Quantification of HBV DNA was not performed and presence of covalently closed circular (ccc) DNA was not analyzed in most studies. We aimed to quantify total and ccc HBV DNA in explant liver and post-orthotopic liver transplantation (OLT) biopsies and to correlate the values with HBV recurrence post-OLT. Frozen liver tissue from 34 patients (9 with explant liver only, 9 with explant liver and post-OLT liver biopsies, and 16 with post-OLT biopsies only) in the National Institutes of Health HBV-OLT study was examined using real-time polymerase chain reaction (PCR). Among the 18 patients with explant liver, 7 were hepatitis B e antigen (HBeAg)-positive, 8 had detectable serum HBV DNA, and 10 received antiviral therapy prior to OLT. Total and ccc HBV DNA was detected in explant livers of 17 and 16 patients, respectively. Of the 10 patients who received antiviral therapy pre-OLT, serum HBV DNA was undetectable in 8 at transplantation but 7 had detectable total and ccc HBV DNA in their explant liver. Of the 25 patients with post-OLT biopsies, total HBV DNA was detected in 83% and ccc DNA in 17% of 47 biopsies, although only 2 patients had HBV recurrence. In conclusion, total and ccc HBV DNA could be detected in explant livers of most patients despite antiviral therapy pre-OLT. Total but not ccc HBV DNA could be detected in post-OLT liver biopsies of most patients despite undetectable serum HBV DNA and hepatitis B surface antigen (HBsAg). Our findings suggest that occult HBV reinfection occurs in most HBV patients after OLT and continued administration of appropriate prophylactic therapy is important in preventing overt HBV recurrence. Liver Transpl 13:1137–1144, 2007. © 2007 AASLD.. Peer Reviewed. http://deepblue.lib.umich.edu/bitstream/2027.42/56161/1/21179_ftp.pdf

Publication details
Download , http://hdl.handle.net/2027.42/56161
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17663390&dopt=citation
http://dx.doi.org/10.1002/lt.21179
Publisher Wiley Subscription Services, Inc., A Wiley Company
Contributors Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI ; Telephone: 734-615-4628; FAX: 734-936-7392 ; University of Michigan Medical Center, 1500 East Medical Center Drive, 3912 Taubman Center, Box 0362, Ann Arbor, MI 48109-0362, Section of Hepatobiliary Disease, Department of Medicine, University of Florida, Gainesville, FL, Division of Transplant Surgery, Department of Surgery, Mount Sinai Medical Center, New York, NY, Hepatology Section, Division of Gastroenterology, Department of Medicine, Virginia Commonwealth University, Richmond, VA
Repository University of Michigan (United States)
Keywords Life and Medical Sciences, Surgery, Health Sciences